Seo Salimi is a partner in Goodwin's Technology Companies & Life Sciences Group. His practice focuses on corporate transactions and securities laws with a particular emphasis on representing clients in public and private capital markets transactions such as initial public offerings, follow-on offerings and private placements of equity and debt securities. His clients include global investment banks, issuers and venture capital investors. His experience extends to a variety of industries, with a focus on life sciences.

Experience

ERFAHRUNG

工作经历

Mr. Salimi also routinely counsels clients on corporate governance matters, federal and state securities law issues and rules and interpretations of the Financial Industry Regulatory Authority and various trading markets, including the NYSE and NASDAQ. A selection of Mr. Salimi’s recent representations include:

Domestic Representations 

  • JP Morgan and Goldman Sachs as underwriters in a $300 million follow-on offering by Sarepta Therapeutics, Inc.
  • Morgan Stanley and Credit Suisse as underwriter in $125 million follow-on offering of Sarepta Therapeutics
  • Citigroup as underwriter in the $60 million initial public offering of Reata Pharmaceuticals Inc.
  • Cowen and Company in “At-the-Market” transactions for various life science companies
  • Cowen and Company, as underwriter in a $143.8 million public offering of Dynavax Technologies
  • Credit Suisse and Bank of America  in the $90 million initial public offering by Everbridge, Inc. 
  • Repligen Corporation in $115 million senior convertible notes offering
  • General company representation of Repligen Corp

Cross-Border Representations

  • CRISPR Therapeutics AG in its $62 million initial public offering (Country of Issuer: Switzerland)
  • General company representation of CRISPR Therapeutics AG    
  • Citigroup and Morgan Stanley, as underwriters in a $280 million follow-on offering of American Depositary Shares by DBV Technologies (Country of Issuer: France)
  • Citigroup as underwriter in the $70 million initial public offering of AC Immune SA (Country of Issuer: Switzerland)
  • H.C. Wainwright in a public offering by Aurinia Pharmaceuticals Inc. (Country of Issuer: Canada)
 
Professional Activities

Mr. Salimi is a member of the California and New York bar associations.

Recognition

Prior to joining Goodwin, Mr. Salimi was an associate at Latham & Watkins LLP and Hogan Lovells LLP. Mr. Salimi also served as the General Counsel of a NASDAQ listed company.

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2004
University of Southern California, Gould School of Law
B.A., 2001
University of California, Irvine

Admissions

Bar

New York
California
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师